IP Library › Granted Patent US 12,433,665
Granted Patent B2
US 12,433,665 · App. 18/087,035 · Granted Oct 7, 2025

Surgical instruments incorporating ultrasonic and electrosurgical functionality

Inventors: David J. Van Tol (Boulder, CO); Thomas W. Meiser (Lakewood, CO)
Assignee: Covidien LP
A61B18/1445A61B17/320092A61B18/1447A61B2017/2926A61B2017/320075A61B2017/320082A61B2017/320094A61B2017/320095A61B2018/00196A61B2018/00601A61B2018/0063A61B2018/00916A61B2018/00922A61B2018/00946A61B2018/00994A61B2018/1452
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,433,665
App. No.
18/087,035
Filed
Dec 22, 2022
Granted
Oct 7, 2025
Kind
B2
Art Unit
3794
USPC
606/52
Abstract

A surgical instrument end effector assembly includes a first jaw member defining an insulative tissue-contacting surface and first and second electrically-conductive tissue-contacting surfaces disposed on either side of the insulative tissue-contacting surface. A second jaw member includes an ultrasonic blade body positioned to oppose the insulative tissue-contacting surface of the first jaw member. The first jaw member is movable relative to the second jaw member between a spaced-apart position and an approximated position to apply a first grasping force to tissue disposed therebetween. A slider is movable, independent of the first jaw member, between a retracted position, wherein the slider is disposed proximally of the first and second jaw members, and an extended position, wherein the slider extends about the first jaw member and urges the first jaw member from the approximated position further towards the second jaw member to apply a second, greater grasping force to tissue.

Claims (37)

1. A surgical instrument, comprising:

an end effector assembly, including:

a first jaw member including first and second electrodes and a flexible joint interconnecting the first and second electrodes, the flexible joint defining an insulative tissue-contacting surface and the first and second electrodes defining first and second electrically-conductive tissue-contacting surfaces, respectively, disposed on either side of the insulative tissue-contacting surface, the first and second electrodes adapted to connect to a source of electrosurgical energy; and

a second jaw member including an ultrasonic blade body adapted to receive ultrasonic energy from an ultrasonic waveguide and positioned to oppose the insulative tissue-contacting surface of the first jaw member,

wherein the first jaw member is movable relative to the second jaw member between a spaced-apart position and an approximated position, and wherein, upon movement of the first jaw member from the spaced-apart position to the approximated position, the flexible joint is flexed from a first configuration, wherein the insulative tissue-contacting surface and the first and second electrically-conductive tissue-contacting surfaces are generally co-planar, to a second configuration, wherein the first and second electrically-conductive tissue-contacting surfaces are angled inwardly towards one another.

2. The surgical instrument according to claim 1 , wherein the first jaw member further includes first and second spaced-apart support shafts positioned adjacent the first and second electrodes, respectively, wherein the first and second support shafts are movable relative to the second jaw member to move the first jaw member between the spaced-apart and approximated positions and to flex the flexible joint between the first configuration and the second configuration.

3. The surgical instrument according to claim 1 , wherein, in the approximated position of the first jaw member and the second configuration of the flexible joint, the first jaw member generally conforms about the second jaw member.

4. The surgical instrument according to claim 1 , wherein the ultrasonic blade body is adapted to connect to a source of electrosurgical energy.

5. The surgical instrument according to claim 1 , wherein the first and second electrically-conductive tissue-contacting surfaces are electrically-isolated from one another and energizable to different potentials for conducting electrosurgical energy therebetween.

6. The surgical instrument according to claim 1 , wherein the first and second electrically-conductive tissue-contacting surfaces are electrically-coupled to one another and configured to conduct energy from the first and second electrically-conductive tissue-contacting surfaces to the ultrasonic blade body.

7. The surgical instrument according to claim 1 , further comprising:

a housing;

a shaft extending distally from the housing; and

an ultrasonic waveguide extending through the shaft,

wherein the end effector assembly is supported at a distal end portion of the shaft.

8. The surgical instrument according to claim 7 , further comprising a trigger operably associated with the housing and coupled to the first jaw member, the trigger selectively actuatable to move the first jaw member relative to the second jaw member between the spaced-apart position and the approximated position and to flex the flexible joint between the first configuration and the second configuration.

9. A surgical instrument, comprising:

an end effector assembly, including:

an ultrasonic blade body configured to transmit ultrasonic energy to tissue to treat tissue; and

a jaw member including first and second tissue-contacting surfaces and a joint interconnecting the first and second tissue-contacting surfaces, the jaw member movable relative to the ultrasonic blade body between a spaced-apart position and an approximated position, wherein, upon movement of the jaw member from the spaced-apart position to the approximated position, the first and second tissue-contacting surfaces are rotated about an axis that is parallel to the ultrasonic blade body and moved relative to one another inwardly towards the ultrasonic blade body, and wherein the jaw member is configured to conduct electrosurgical energy through tissue to treat tissue.

10. The surgical instrument according to claim 9 , wherein, in the approximated position, the jaw member generally conforms about the ultrasonic blade body.

11. The surgical instrument according to claim 9 , wherein the jaw member and the ultrasonic blade body are configured to conduct electrosurgical energy therebetween and through tissue to treat tissue.

12. The surgical instrument according to claim 9 , wherein the first and second tissue-contacting surfaces are electrically-conductive and electrically-isolated from one another by the joint.

13. The surgical instrument according to claim 12 , wherein the first and second tissue-contacting surfaces are configured to conduct electrosurgical energy therebetween and through tissue to treat tissue.

14. The surgical instrument according to claim 9 , wherein the joint is a flexible joint.

15. The surgical instrument according to claim 9 , further comprising:

a housing;

a shaft extending distally from the housing, wherein the end effector is supported at a distal end portion of the shaft; and

an ultrasonic transducer, the ultrasonic transducer configured to transmit ultrasonic energy to the ultrasonic blade body.

16. The surgical instrument according to claim 9 , further comprising a first actuator operably coupled to the jaw member and configured to initiate movement of the jaw member between the spaced-apart position and the approximated position.

17. The surgical instrument according to claim 9 , further comprising an activation switch configured, in a first mode, to at least initiate supply of ultrasonic energy to the ultrasonic blade body, and, in a second mode, to at least initiate supply of electrosurgical energy to the jaw member.

18. The surgical instrument according to claim 9 , wherein, during a first portion of movement of the jaw member relative to the ultrasonic blade body from the spaced-apart position to the approximated position, the first and second tissue-contacting surfaces are maintained in an initial configuration and wherein, during a second portion of the movement of the jaw member relative to the ultrasonic blade body from the spaced-apart position to the approximated position, the first and second tissue-contacting surfaces are moved about the joint inwardly towards the ultrasonic blade body from the initial configuration to an angled configuration.

19. The surgical instrument according to claim 9 , wherein the joint includes a compliant jaw liner configured to oppose the ultrasonic blade body in the approximated position.

20. A surgical instrument, comprising:

an end effector assembly, including:

an ultrasonic blade body configured to transmit ultrasonic energy to tissue to treat tissue; and

a jaw member including first and second tissue-contacting surfaces and a joint interconnecting the first and second tissue-contacting surfaces, the jaw member movable relative to the ultrasonic blade body between a spaced-apart position and an approximated position, wherein, upon movement of the jaw member from the spaced-apart position to the approximated position, the first and second tissue-contacting surfaces are moved about the joint and relative to one another inwardly towards the ultrasonic blade body, and wherein the jaw member is configured to conduct electrosurgical energy through tissue to treat tissue, wherein the jaw member further includes first and second spaced-apart support shafts movable relative to the ultrasonic blade body to move the jaw member between the spaced-apart position and the approximated position and to move the first and second tissue-contacting surfaces about the joint.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: VAN TOL, DAVID J.
To: COVIDIEN LP
Reel/Frame 062185/0392 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: MEISER, THOMAS W.
To: COVIDIEN LP
Reel/Frame 062185/0513 →
Continuity (6)
Division 16238812 · Jan 3, 2019
Provisional Application 62618402 · Jan 17, 2018
Provisional Application 62618241 · Jan 17, 2018
Provisional Application 62618277 · Jan 17, 2018
Provisional Application 62618292 · Jan 17, 2018
Related Publication 20230124774A1 · Apr 20, 2023
References Cited (128)
US 617247A · Gholson · 1899 [cited by applicant]
US 1352978A · Lantieri · 1920 [cited by applicant]
US 2031682A · Wappler et al. · 1936 [cited by applicant]
US 3685518A · Beuerle et al. · 1972 [cited by applicant]
US 3911241A · Jarrard · 1975 [cited by applicant]
US 3911926A · Peters · 1975 [cited by applicant]
US 4003380A · Wien · 1977 [cited by applicant]
US 4248224A · Jones · 1981 [cited by applicant]
US 4478219A · Dujovny · 1984 [cited by applicant]
US 4686965A · Bonnet · 1987 [cited by applicant]
US 4712545A · Honkanen · 1987 [cited by applicant]
US 4850110A · Meier, Jr. · 1989 [cited by applicant]
US 4919129A · Weber, Jr. et al. · 1990 [cited by applicant]
US 5190517A · Zieve et al. · 1993 [cited by applicant]
US 5250056A · Hasson · 1993 [cited by applicant]
US 5261917A · Hasson et al. · 1993 [cited by applicant]
US 5261918A · Phillips et al. · 1993 [cited by applicant]
US 5308357A · Lichtman · 1994 [cited by applicant]
US 5312329A · Beaty et al. · 1994 [cited by applicant]
US 5322055A · Davison et al. · 1994 [cited by applicant]
US 5443463A · Stern et al. · 1995 [cited by applicant]
US 5452837A · Williamson, IV et al. · 1995 [cited by applicant]
US 5499998A · Meade · 1996 [cited by applicant]
US 5810811A · Yates et al. · 1998 [cited by applicant]
US 6152923A · Ryan · 2000 [cited by applicant]
US 6251110B1 · Wampler · 2001 [cited by applicant]
US 6257241B1 · Wampler · 2001 [cited by applicant]
US 6416486B1 · Wampler · 2002 [cited by applicant]
US 6562032B1 · Ellman et al. · 2003 [cited by applicant]
US 6736814B2 · Manna et al. · 2004 [cited by applicant]
US 7717913B2 · Novak et al. · 2010 [cited by applicant]
US 7905881B2 · Masuda · 2011 [cited by examiner]
US 8221417B2 · Rioux et al. · 2012 [cited by applicant]
US 8267936B2 · Hushka et al. · 2012 [cited by applicant]
US 8529565B2 · Masuda · 2013 [cited by applicant]
US 8764747B2 · Cummings et al. · 2014 [cited by applicant]
US 8773001B2 · Wiener et al. · 2014 [cited by applicant]
US 9700366B2 · Paulus · 2017 [cited by applicant]
US 11446079B2 · Kabala et al. · 2022 [cited by applicant]
US 11564733B2 · Van Tol et al. · 2023 [cited by applicant]
US 11589889B2 · Meiser et al. · 2023 [cited by applicant]
US 20010051803A1 · Desai et al. · 2001 [cited by applicant]
US 20020099373A1 · Schulze et al. · 2002 [cited by applicant]
US 20020107517A1 · Witt et al. · 2002 [cited by applicant]
US 20020165564A1 · Danitz · 2002 [cited by applicant]
US 20030158549A1 · Swanson · 2003 [cited by applicant]
US 20040068274A1 · Hooven · 2004 [cited by applicant]
US 20060015095A1 · Desinger et al. · 2006 [cited by applicant]
US 20060178667A1 · Sartor et al. · 2006 [cited by applicant]
US 20070173814A1 · Hixson et al. · 2007 [cited by applicant]
US 20070173872A1 · Neuenfeldt · 2007 [cited by applicant]
US 20080172048A1 · Martin et al. · 2008 [cited by applicant]
US 20080234710A1 · Neurohr et al. · 2008 [cited by applicant]
US 20090125012A1 · Rioux et al. · 2009 [cited by applicant]
US 20090248021A1 · McKenna · 2009 [cited by applicant]
US 20100137854A1 · Hosier · 2010 [cited by applicant]
US 20100145329A1 · Bystryak et al. · 2010 [cited by applicant]
US 20100145335A1 · Johnson et al. · 2010 [cited by applicant]
US 20100292716A1 · Kasvikis et al. · 2010 [cited by applicant]
US 20110015627A1 · DiNardo et al. · 2011 [cited by applicant]
US 20110087256A1 · Wiener et al. · 2011 [cited by applicant]
US 20110238078A1 · Goode · 2011 [cited by applicant]
US 20120150176A1 · Weizman · 2012 [cited by applicant]
US 20120203143A1 · Sanai et al. · 2012 [cited by applicant]
US 20130018364A1 · Chernov · 2013 [cited by examiner]
US 20130066311A1 · Smith et al. · 2013 [cited by applicant]
US 20140005682A1 · Worrell · 2014 [cited by examiner]
US 20140067015A1 · Kothandaraman et al. · 2014 [cited by applicant]
US 20140114327A1 · Boudreaux et al. · 2014 [cited by applicant]
US 20140135804A1 · Weisenburgh, II et al. · 2014 [cited by applicant]
US 20140330271A1 · Dietz · 2014 [cited by applicant]
US 20150088128A1 · Couture · 2015 [cited by applicant]
US 20150141981A1 · Price et al. · 2015 [cited by applicant]
US 20150148804A1 · Rooks et al. · 2015 [cited by applicant]
US 20150148831A1 · Faller et al. · 2015 [cited by applicant]
US 20150164531A1 · Faller et al. · 2015 [cited by applicant]
US 20150164533A1 · Felder et al. · 2015 [cited by applicant]
US 20150182251A1 · Messerly et al. · 2015 [cited by applicant]
US 20150282867A1 · Keller et al. · 2015 [cited by applicant]
US 20160015448A1 · Longoria et al. · 2016 [cited by applicant]
US 20160038220A1 · Twomey · 2016 [cited by applicant]
US 20160228138A1 · Rodriguez-Navarro · 2016 [cited by applicant]
US 20160317216A1 · Hermes et al. · 2016 [cited by applicant]
US 20170007317A1 · Allen, IV et al. · 2017 [cited by applicant]
US 20170105754A1 · Boudreaux et al. · 2017 [cited by applicant]
US 20170164973A1 · Lesko · 2017 [cited by applicant]
US 20170164997A1 · Johnson · 2017 [cited by applicant]
US 20170202570A1 · Shelton, IV et al. · 2017 [cited by applicant]
US 20170202609A1 · Shelton, IV · 2017 [cited by applicant]
US 20170333031A1 · Al-Haqan · 2017 [cited by applicant]
US 20170354458A1 · Wang · 2017 [cited by applicant]
US 20180125569A1 · Vaders et al. · 2018 [cited by applicant]
US 20180368911A1 · van Overdam · 2018 [cited by applicant]
US 20190216491A1 · Meiser et al. · 2019 [cited by applicant]
US 20210038292A1 · Kabala et al. · 2021 [cited by applicant]
US 20220387097A1 · Kabala et al. · 2022 [cited by applicant]
US 20230200838A1 · Meiser et al. · 2023 [cited by applicant]
US 20250009379A1 · Meiser et al. · 2025 [cited by applicant]
DE 202017004226U1 · 2017 [cited by applicant]
EP 2322111A1 · 2011 [cited by applicant]
EP 2474280A1 · 2012 [cited by applicant]
EP 2583633A1 · 2013 [cited by applicant]
EP 2829245A1 · 2015 [cited by applicant]
EP 2946737A1 · 2015 [cited by applicant]
EP 3117790A1 · 2017 [cited by applicant]
WO 9517855A1 · 1995 [cited by applicant]
WO 2017100423A2 · 2017 [cited by applicant]
WO 2017123837A2 · 2017 [cited by applicant]
Extended European Search Report issued in corresponding European Application No. 20201742.2 dated Feb. 10, 2021, 8 pages. [cited by applicant]
Extended European Search Report issued in European Application No. 19152026.1 dated Jun. 28, 2019, 6 pages. [cited by applicant]
Extended European Search Report issued in European Application No. 19152133.5 dated Jun. 28, 2019, 6 pages. [cited by applicant]
European Search Report issued in corresponding European Application No. 19152028.7 dated Jul. 17, 2019, 11 pages. [cited by applicant]
Extended European Search Report issued in corresponding European Application No. 20195714.9 dated Dec. 21, 2020, 8 pages. [cited by applicant]
Extended European Search Report issued in corresponding European Application No. 19152030.3 dated Apr. 10, 2019, 8 pages. [cited by applicant]
Partial European Search Report issued in corresponding European Application No. 19152028.7 dated Apr. 12, 2019, 12 pages. [cited by applicant]
Communication Pursuant to Article 94(3) EPC issued in corresponding European Application No. 19152028.7 dated May 7, 2021, 5 pages. [cited by applicant]
Advisory Action received for U.S. Appl. No. 16/238,668, mailed on Mar. 11, 2022, 4 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 16/238,754, mailed on Apr. 11, 2022, 14 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 16/238,812, mailed on Apr. 1, 2022, 10 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 17/078,204, mailed on Apr. 3, 2023, 8 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 17/078,204, mailed on Jan. 23, 2024, 12 pages. [cited by applicant]
Final Office Action received for U.S. Appl. No. 17/890,397, mailed on Nov. 25, 2024, 9 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 16/238,600, mailed on Feb. 24, 2022, 18 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 16/238,668, mailed on Aug. 31, 2021, 8 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 16/238,812, mailed on Oct. 15, 2021, 14 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 17/078,204, mailed on Dec. 20, 2022, 7 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 17/078,204, mailed on Sep. 28, 2023, 10 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 17/890,397, mailed on Aug. 14, 2024, 8 pages. [cited by applicant]